Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  International Immunology

• Publication date

  1992-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INTIMM/4.10.1085PMID 1283332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry.

  1992cited by this paper
• On the nature of peptides involved in T cell alloreactivity

  1991cited by this paper
• Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

  1991cited by this paper
• Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

  1991cited by this paper
• Identification of self peptides bound to purified HLA-B27

  1991cited by this paper
• Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.

  1991cited by this paper
• H-2Kd-restricted antigenic peptides share a simple binding motif

  1991cited by this paper
• The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

  1991cited by this paper
• Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast

  1991cited by this paper
• Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway.

  1991cited by this paper
• Peptide-induced antiviral protection by cytotoxic T cells.

  1991cited by this paper
• A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

  1991cited by this paper
• Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.

  1991cited by this paper
• Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression.

  1991cited by this paper
• Exact prediction of a natural T cell epitope

  1991cited by this paper
• Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule

  1990cited by this paper
• Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide

  1990cited by this paper
• Cellular peptide composition governed by major histocompatibility complex class I molecules

  1990cited by this paper
• Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

  1990cited by this paper
• Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

  1990cited by this paper
• Empty MHC class I molecules come out in the cold

  1990cited by this paper
• The role of beta 2-microglobulin in peptide binding by class I molecules.

  1990cited by this paper
• Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y.

  1990cited by this paper
• In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

  1989cited by this paper
• Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

  1989cited by this paper
• A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes

  1989cited by this paper
• Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.

  1988cited by this paper
• Structure of the human class I histocompatibility antigen, HLA-A2

  1987cited by this paper
• The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

  1986cited by this paper
• Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin.

  1984cited by this paper
• Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant‐specific antigens by selection of antigen‐loss variants with cytolytic T cell clones

  1982cited by this paper
• Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response

  1982cited by this paper
• Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

  1980cited by this paper
• Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens

  1976cited by this paper
• Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system

  1974cited by this paper

• The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy

  2021cites this paper
• Vaccines in RCC: Clinical and Biological Relevance

  2015cites this paper
• From Basic Immunology to New Therapies for Cancer Patients

  2014cites this paper
• Structural and functional characterization of a single-chain peptide–MHC molecule that modulates both naive and activated CD8+ T cells

  2011cites this paper
• MHC restriction and allogeneic immune responses

  2008cites this paper
• Intrathymic selection: new insight into tumor immunology.

  2007cites this paper
• Structural Definition of the H-2Kd Peptide-binding Motif*

  2006cites this paper
• Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells

  2006cites this paper
• High Epitope Expression Levels Increase Competition between T Cells

  2006cites this paper
• Identification of naturally processed peptides bound to the class I MHC molecule H‐2Kd of normal and TAP‐deficient cells

  2006cites this paper
• MHC Restriction and Allogeneic Immune Response

  2005cites this paper
• HLA-Klasse-I-Antigenpräsentation und Genexpression solider Tumoren im Vergleich

  2005cites this paper
• Identification of two naturally presented MAGE antigenic peptides from a patient with hepatocellular carcinoma by mass spectrometry.

  2005cites this paper
• MHC ligands and peptide motifs: first listing

  2004cites this paper
• Characterization of major histocompatibility complex-associated peptides from a small volume of whole blood.

  2004cites this paper
• The use of HPLC-MS in T-cell epitope identification.

  2003cites this paper
• Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.

  2003cites this paper
• Prediction of autoimmune diabetes in the non-obese diabetic mouse by ex vivo analysis of autoreactive cytotoxic T lymphocytes

  2003cites this paper
• CD40 triggering increases the efficiency of dendritic cells for antitumoral immunization.

  2002cites this paper
• Identifizierung krankheitsassoziierter MHC-Liganden durch massenspektrometrische Verfahren

  2001cites this paper
• Identification of tumor‐associated MHC class I ligands by a novel T cell‐independent approach

  2000cites this paper
• Recognition of a Sequestered Self Peptide by Influenza Virus-Specific CD8+ Cytolytic T Lymphocytes1

  2000cites this paper
• Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.

  1999cites this paper
• Individual TCR Signaling Events Ligands : Relationship to the Quality of Down-Modulation by Peptide : MHC Molecule Serial TCR Engagement and

  1999cites this paper
• Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.

  1999cites this paper
• Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.

  1999cites this paper
• The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors— lessons from normal and immunodeficient mice

  1999cites this paper
• Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

  1999cites this paper
• High MHC class I expression correlates with slow growth in UV‐induced skin carcinomas in hairless mice

  1998cites this paper
• A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.

  1997cites this paper
• Recognition by Immune Cells

  1997cites this paper
• Islet antigen-specific T cell clones in autoimmune diabetes: from mice to men.

  1997cites this paper
• Mechanisms influencing the selection of T cell epitopes by MHC class II molecules.

  1997cites this paper
• The Susceptibility to Cytotoxic T Lymphocyte Mediated Lysis of Chemically Induced Sarcomas from Immunodeficient and Normal Mice

  1997cites this paper
• Tumor antigens recognized by T lymphocytes

  1997cites this paper
• Anti-melanoma cytotoxic T lymphocytes (CTL) recognize numerous antigenic peptides having 'self' sequences: autoimmune nature of the anti-melanoma CTL response.

  1997cites this paper
• Interferon‐γ‐Induced MHC Class I Expression and Defects in Jak/Stat Signalling in Methylcholanthrene‐Induced Sarcomas

  1997cites this paper
• Class I HLA-restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs

  1996cites this paper
• Human minor histocompatibility antigens.

  1996cites this paper
• Methylcholanthrene‐induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression

  1996cites this paper
• Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice

  1996cites this paper
• Isolation of MHC-restricted peptides by TFA extraction

  1996cites this paper
• Role of Ligand Density in T Cell Reactions

  1996cites this paper
• Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population.

  1995cites this paper
• HLA class I antigens in human tumors.

  1995cites this paper
• Prediction of binding to MHC class I molecules.

  1995cites this paper
• Identification of H‐2Kb Binding and Immunogenic Peptides from Human Papilloma Virus Tumour Antigens E6 and E7

  1995cites this paper
• Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of an in vivo CD8+ T-cell immune response to murine myeloid leukemia.

  1995cites this paper
• Induction of CTL in vivo by major histocompatibility complex class I‐peptide complexes covalently associated on the cell surface

  1995cites this paper
• Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6.

  1995cites this paper
• Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.

  1995cites this paper
• Structure of peptides associated with MHC class I molecules.

  1994cites this paper
• Tumor antigens recognized by T lymphocytes.

  1994cites this paper
• Molecular mechanisms and clinical applications of human melanoma specific immunity.

  1994cites this paper
• Both major and minor peptide-binding pockets in HLA-A2 influence the presentation of influenza virus matrix peptide to cytotoxic T lymphocytes.

  1994cites this paper
• Structure of peptides associated with class I and class II MHC molecules.

  1994cites this paper
• Polyclonal uses of T-cell receptor (TCR)alpha and beta genes for cytotoxic T lymphocytes in human metastatic melanoma: possible involvement of TCR alpha in tumor-cell recognition.

  1994cites this paper
• Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1

  1994cites this paper
• Polyclonal uses of T‐cell receptor (TCR)α and β genes for cytotoxic T lymphocytes in human metastatic melanoma: possible involvement of TCRα in tumor‐cell recognition

  1994cites this paper
• T-cell antigens in cancer.

  1994cites this paper
• Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells

  1993cites this paper
• Peptides naturally presented by MHC class I molecules.

  1993cites this paper
• Human minor histocompatibility antigens.

  1993cites this paper
• Peptide selection by class I molecules of the major histocompatibility complex.

  1993cites this paper
• MHC molecules as peptide receptors.

  1993cites this paper
• Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?

  1993cites this paper
• Self tolerance of natural MHC class I ligands.

  1993cites this paper